From: Systematic review of predictive performance of injury severity scoring tools
Author | Year | Country | Hospital | Tool | AUROC | N | Mortality | Mechanism | Code | Age |
---|---|---|---|---|---|---|---|---|---|---|
Aydin[79] | 2008 | Turkey | 1 | ISS | 0.907 | 550 | 21.6% | ND | AIS90 | >16 |
 |  |  |  | NISS | 0.914 |  |  |  |  |  |
 |  |  |  | TRISS (M) | 0.934 |  |  |  |  |  |
Barbieri[31] | 2004 | Italy | 1 | TRISS (M) | 0.946 | 93 | 28.0% | ND | ND | ND |
Becalick[32] | 2001 | UK | 1 | TRISS (N) | 0.941 | 677 | 16.2% | B + P | ND | ND |
Bergeron[33] | 2004 | Canada | 1 | TRISS (M) | 0.873 | 5,672 | 6.9% | B | ND | ≥15 |
 |  |  |  | TRISS (N) | 0.878 |  |  |  |  |  |
Bijsma[34] | 2004 | Netherland | 1 | ISS | 0.84 | 668 | 18.4% | ND | ND | ND |
Bonaventura[80] | 2001 | Czekoslovakia | 1 | ISS | 0.57 | 1,113 | 18.0% | ND | ND | ND |
 |  |  |  | TRISS (M) | 0.78 |  |  |  |  |  |
Bouamra[35] | 2006 | UK | 106 | TRISS (N) | 0.937 | 20,895 | 4.4% | B | ND | adult |
Bouillon[36] | 1997 | Germany | 32 | ISS | 0.961 | 612 | 30.9% | ND | AIS90 | all |
 |  |  |  | TRISS (M) | 0.974 |  |  |  |  |  |
Brenneman[37] | 1998 | Canada | 1 | ISS | 0.799 | 2,328 | 13.0% | B | ND | all |
 |  |  |  | NISS | 0.852 |  |  |  |  |  |
Burd[19] | 2008 | US | Multiple | ICISS (T) | 0.726 | 276,366*1 | 2.8% | B + P | ICD9CM | all |
 |  |  |  | SWI (T) | 0.743 |  |  |  |  |  |
 |  |  |  | ICISS (I) | 0.793 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.855 | 312,592*2 | 5.1% |  |  |  |
 |  |  |  | SWI (T) | 0.866 |  |  |  |  |  |
 |  |  |  | ICISS (I) | 0.867 |  |  |  |  |  |
Chytra[81] | 1999 | Czekoslovakia | 1 | ISS | 0.89 | 165*3 | 17.0% | ND | ND | ≥18 |
 |  |  |  | TRISS (M) | 0.85 |  |  |  |  |  |
 |  |  |  | ISS | 0.76 | 109*4 | 38.0% |  |  |  |
 |  |  |  | TRISS (M) | 0.83 |  |  |  |  |  |
Davie[38] | 2008 | New Zealand | ND | ICISS (T) | 0.777 | 186,835 | 5.3% | ND | ICD10AM | ND |
 |  |  |  | ICISS (T) | 0.851 |  |  |  |  |  |
Dillion[39] | 2005 | UK | ND | ISS | 0.832 | 53,286 | 4.1% | B | ND | ≥16 |
 |  |  |  | NISS | 0.827 |  |  |  |  |  |
 |  |  |  | TRISS (N) | 0.939 | 12,606 | 4.4% |  |  |  |
DiRusso[40] | 2000 | US | 25 | ISS | 0.766 | 2,768 | 8.4% | all | ND | all |
 |  |  |  | TRISS (M) | 0.895*5 |  |  |  |  |  |
 |  |  |  | TRISS (M) | 0.918*6 | 2,673 | 8.3% |  |  |  |
 |  |  |  | TRISS (N) | 0.92 | 2,768 | 8.4% |  |  |  |
Eftekhar[41] | 2005 | Iran | 6 | ISS | 0.944 | 7,226 | 3.8% | all | AIS90 | all |
 |  |  |  | TRISS (M) | 0.969 |  |  |  |  |  |
Fischler[42] | 2007 | Switzerland | 1 | ISS | 0.75 | 208 | 13.0% | ND | ND | adult |
Frankema[43] | 2002 | Netherland | 1 | TRISS (M) | 0.975 | 1,024 | 6.9% | B + P | AIS90 | ≥15 |
Frankema[44] | 2005 | Netherland | 1 | TRISS (M) | 0.94 | 1,102 | 11.0% | B + P | AIS90 | ≥15 |
Gabbe[45] | 2005 | Australia | Multiple | TRISS (M) | 0.87 | 1,387 | 4.4% | B | NR | all |
Glance[47] | 2009 | US | 359 | ISS | 0.868 | 66,214 | 4.2% | B + P | ND | ≥1 |
 | 2009 | US | 68 | SWI (T) | 0.862 | 749,374 | 5.0% | B + P | ICD9CM | ≥1 |
Glance[46] | Â | Â | Â | ICISS (T) | 0.85 | Â | Â | Â | Â | Â |
Guzzo[48] | 2005 | US | 1 | ISS | 0.791 | 2,412 | 15.1% | all | ND | all |
 |  |  |  | TRISS (M) | 0.97 |  |  |  |  |  |
Hannan[50] | 1999 | US | 192 | TRISS (M) | 0.858 | 20,883 | 7.2% | B | AIS90 | ≥13 |
 |  |  |  | TRISS (N) | 0.857 |  |  |  |  |  |
Hannan[7] | 2005 | US | 192 | ISS | 0.776 | 39,534 | 6.9% | B | AIS90 | ND |
 |  |  |  | NISS | 0.786 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.809 |  |  |  |  |  |
Hannan[49] | 2007 | US | ND | SWI (I) | 0.754 | 117,630 | 2.9% | all | ICD9CM | ≥12 |
 |  |  |  | SWI (T) | 0.764 |  |  |  |  |  |
 |  |  |  | ICISS (I) | 0.744 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.745 |  |  |  |  |  |
Harwood[51] | 2006 | 4 countries (Germany, Netherlands, Switzerland, Austria) | 82 | ISS | 0.78 | 10,062 | NR | B | ND | ≥16 & ≤70 |
 |  |  | NISS | 0.785 |  |  |  |  |  | |
 |  |  | ISS | 0.787 | 549 | NR | P |  |  | |
 |  |  | NISS | 0.793 |  |  |  |  |  | |
Hunter[52] | 2000 | UK | ND | TRISS (M) | 0.9411 | 7,831 | NR | ND | ND | ND |
 |  |  |  | TRISS (N) | 0.9426 |  |  |  |  |  |
Jamulitrat[53] | 2001 | Thailand | 1 | ISS | 0.966 | 2,044 | 5.6% | all | AIS90 | all |
 |  |  |  | NISS | 0.974 |  |  |  |  |  |
Kilgo[54] | 2006 | US | 125 | TRISS (M) | 0.939 | 310,958 | 5.0% | B + P | ND | all |
 |  |  |  | TRISS (N) | 0.95 |  |  |  |  |  |
Kim[8] | 1999 | Korea | 2 | ISS | 0.892 | 367 | 21.3% | B | ND for AIS | ND |
 |  |  |  | ICISS (T)*7 | 0.843 |  |  |  | ICD10 |  |
 |  |  |  | ICISS (T)*8 | 0.909 |  |  |  | ICD9CM |  |
 |  |  |  | TRISS (N) | 0.958 |  |  |  |  |  |
Kroezen[55] | 2007 | Netherland | 2 | TRISS (M) | 0.806 | 349 | 14.0% | B + P | ND | all |
 |  |  |  | TRISS (N) | 0.891 | 179 | 22.0% |  |  |  |
Kuhls[56] | 2002 | US | 1 | ISS | 0.93 | 3,855 | 3.5% | B + P | ND | all |
 |  |  |  | TRISS (M) | 0.96 |  |  |  |  |  |
Lane[57] | 1996 | Canada | 12 | TRISS (N) | 0.908 | 1,793 | 7.9% | ND | AIS90 | ND |
Lavoie[58] | 2004 | Canada | 3 | ISS | 0.818 | 23,306 | 6.3% | B | ND | ≥16 |
 |  |  |  | NISS | 0.824 |  |  |  |  |  |
 |  |  |  | ISS | 0.84 | 957 | 15.9% | P |  |  |
 |  |  |  | NISS | 0.824 |  |  |  |  |  |
 |  |  |  | ISS | 0.819 | 24,263 | 6.6% | B + P |  |  |
 |  |  |  | NISS | 0.827 |  |  |  |  |  |
Macleod[59] | 2003 | Uganda | 1 | ISS | 0.811 | 150 | 25.5% | all | ND | ≥16 |
 |  |  |  | TRISS (M) | 0.871 |  |  |  |  |  |
Meredith[9] | 2002 | US | ND | ISS | 0.876 | 76,871 | 5.3% | B + P | ND for AIS | all |
 |  |  |  | NISS | 0.871 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.893 |  |  |  | ICD9CM |  |
Meredith[60] | 2003 | US | 88 | ICISS (T)*9 | 0.89 | 170,853 | 5.4% | B + P | ICD9CM | all |
 |  |  |  | ICISS (T)*10 | 0.882 |  |  |  |  |  |
Meredith[61] | 2003 | US | ND | ICISS (I) | 0.892 | 192,347 | 5.1% | B + P | ICD9CM | all |
 |  |  |  | ICISS (T) | 0.875 |  |  |  |  |  |
Millham[62] | 2004 | US | ND | TRISS (M) | 0.837 | 31,000 | 4.6% | B | ND | all |
 |  |  |  | TRISS (N) | 0.936 |  |  |  |  |  |
 |  |  |  | TRISS (M) | 0.982 | 5,200 | 9.9% | P |  |  |
 |  |  |  | TRISS (N) | 0.981 |  |  |  |  |  |
Moore[10] | 2008 | Canada | ND | ISS | 0.822 | 25,111 | 7.3% | B + P | AIS90 | ≥16 |
 |  |  |  | NISS | 0.831 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.852 |  |  |  | ICD9 |  |
Moore[63] | 2009 | Canada, US | Multiple | TRISS (N) | 0.928 | 178,377 | 6.2% | B | ND | >16 |
Osler[11] | 1996 | US | 1 | ISS | 0.866 | 2,337 | NR | B | ICD9 | all |
 |  |  |  | ICISS (T) | 0.918 |  |  |  |  |  |
 |  |  |  | ISS | 0.906 | 805 | NR | P |  |  |
 |  |  |  | ICISS (T) | 0.93 |  |  |  |  |  |
 |  |  |  | ISS | 0.87 | 3,142 | 9.0% | B + P |  |  |
 |  |  |  | ICISS (T) | 0.921 |  |  | |||
Osler[3] | 1997 | US | 2 | ISS | 0.869 | 3,136*11 | 9.0% | B + P | AIS90 | all |
 |  |  |  | NISS | 0.896 |  |  |  |  |  |
 |  |  |  | ISS | 0.896 | 3,449*12 | 7.0% |  |  |  |
 |  |  |  | NISS | 0.907 |  |  |  |  |  |
Osler[12] | 1997 | US | 1 | ISS | 0.843 | 1,812 | 2.5% | all | ND for AIS | all |
 |  |  |  | ICISS (T)*13 | 0.884 |  |  |  | ICD9 |  |
 |  |  |  | ICISS (T)*14 | 0.872 |  |  |  |  |  |
Osler[64] | 2008 | US | 206 | ISS | 0.871 | 140,000 | 4.1% | all | ND | ≥1 |
Rabbani[65] | 2007 | Iran | 3 | TRISS (N) | 0.93 | 2,514 | 6.0% | all | ND | all |
Raum[66] | 2009 | 4 countries (Germany, Netherlands, Switzerland, Austria) | 97 | ISS | 0.722 | 1,292 | 18.9% | all | ND | ≥16 |
NISS | 0.764 | Â | Â | Â | Â | Â | ||||
TRISS (M) | 0.851 | Â | Â | Â | Â | Â | ||||
Reiter[67] | 2004 | Australia | Multiple | TRISS (M) | 0.84 | 5,538 | 12.3% | all | ND | ≥18 |
Rhee[68] | 1990 | US | 6 | ISS | 0.7967 | 691 | 15.8% | all | ND | ≥11 |
Rutledge[69] | 1997 | US | ND | ISS | 0.939 | 44,032 | 6.5% | all | ND for AIS | all |
 |  |  |  | ICISS (T)*15 | 0.939 |  |  |  | ICD9CM | |
 |  |  |  | ICISS (T)*16 | 0.929 |  |  |  |  | |
 |  |  |  | ICISS (T)*9 | 0.858 |  |  |  |  | |
 |  |  |  | ICISS (T)*17 | 0.957 |  |  |  |  | |
Rutledge[70] | 1998 | US | Multiple | ICISS (T) | 0.957 | 9,438 | 5.1% | all | ICD9CM | all |
Rutledge[13] | 1998 | US | 13 | ISS | 0.667 | 7,276 | 3.8% | all | ND for AIS | all |
 |  |  |  | ICISS (T) | 0.916 |  |  |  | ICD9CM |  |
 |  |  |  | TRISS (M) | 0.877 |  |  |  |  |  |
Sacco[14] | 1999 | US | 26 | ISS | 0.86 | 30,287 | 7.1% | all | ND for AIS | all |
 |  |  |  | NISS | 0.86 |  |  |  |  |  |
 |  |  |  | ICISS (T)*15 | 0.87 |  |  |  | ICD9CM |  |
 |  |  |  | ICISS (T)*18 | 0.88 |  |  |  |  |  |
Sammour[71] | 2009 | New Zealand | 1 | ISS | 0.8547 | 1,197 | 3.7% | all | ND | ≥15 |
 |  |  |  | TRISS | 0.963 |  |  |  |  |  |
Stephensen[15] | 2002 | New Zealand | ND | ISS | 0.847 | 340,000 | 1.1% | all | AIS90 | all |
 |  |  |  | NISS | 0.829 |  |  |  |  |  |
 |  |  |  | ICISS (T) | 0.901 |  |  |  | ICD9 |  |
Suarez-Alvarez[73] | 1995 | Spain | 1 | TRISS (M) | 0.85 | 404 | 19.6% | B + P | ND | ND |
Tamin[72] | 2008 | Lebanon | 1 | ISS | 0.881 | 891 | 3.6% | all | ND | all |
 |  |  |  | NISS | 0.887 |  |  |  |  |  |
Tay[74] | 2004 | US | 1 | ISS | 0.922 | NR | NR | B | ND | all |
 |  |  |  | NISS | 0.923 |  |  |  |  |  |
 |  |  |  | ISS | 0.943 | NR | NR | P |  |  |
 |  |  |  | NISS | 0.924 |  |  |  |  |  |
 |  |  |  | ISS | 0.942 | 6,089 |  | B + P |  |  |
 |  |  |  | NISS | 0.936 |  |  |  |  |  |
Ulvik[75] | 2007 | Norway | 1 | ISS | 0.61 | 325 | 16.9% | ND | AIS98 | >18 |
Vassar[76] | 1999 | US | 6 | TRISS (M) | 0.82 | 2,414 | 12.3% | B + P | AIS90 | ≥16 |
West[16] | 2000 | US | 1 | ICISS (T) | 0.94 | 9,923 | NR | B + P | ICD9CM, | all |
 |  |  |  | TRISS (M) | 0.947 |  |  |  | AIS90 |  |
Wong[77] | 1996 | Canada | 1 | TRISS (M) | 0.89 | 470 | 13.0% | all | ND | all |
Wong[17] | 2008 | Hong Kong | 1 | ISS | 0.8677 | 1,166 | 13.8% | B | ND for AIS, | all |
 |  |  |  | ICISS (I) | 0.8379 |  |  |  | ICD9 |  |
 |  |  |  | ICISS (T) | 0.851 |  |  |  |  |  |
Zhao[78] | 2008 | China | 1 | ISS | 0.922 | 1,532 | NR | B | ND | ≥16 |
 |  |  |  | NISS | 0.923 |  |  |  |  |  |
 |  |  |  | ISS | 0.943 | 578 | NR | P |  |  |
 |  |  |  | NISS | 0.922 |  |  |  |  |  |
 |  |  |  | ISS | 0.943 | 2,110 | NR | B + P |  |  |
 |  |  |  | NISS | 0.938 |  |  |  |  |  |